"Leukemia, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Descriptor ID |
D015458
|
| MeSH Number(s) |
C04.557.337.428.580 C15.604.515.560.575 C20.683.515.528.582
|
| Concept/Terms |
Leukemia, T-Cell- Leukemia, T-Cell
- Leukemia, T Cell
- Leukemia, Lymphocytic, T-Cell
- Lymphocytic Leukemia, T-Cell
- Leukemia, T-Cell Lymphocytic
- Leukemias, T-Cell Lymphocytic
- Lymphocytic Leukemia, T Cell
- Lymphocytic Leukemias, T-Cell
- T-Cell Lymphocytic Leukemia
- T-Cell Lymphocytic Leukemias
- T-Cell Leukemia
- Leukemias, T-Cell
- T Cell Leukemia
- T-Cell Leukemias
- T-Lymphocytic Leukemia
- Leukemia, T-Lymphocytic
- Leukemias, T-Lymphocytic
- T-Lymphocytic Leukemias
- Leukemia, Lymphocytic, T Cell
- T Lymphocytic Leukemia
- Leukemia, T Lymphocytic
- Leukemias, T Lymphocytic
- Lymphocytic Leukemia, T
- Lymphocytic Leukemias, T
- T Lymphocytic Leukemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, T-Cell".
This graph shows the total number of publications written about "Leukemia, T-Cell" by people in this website by year, and whether "Leukemia, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 1 | 3 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 3 | 2 | 5 |
| 2004 | 3 | 1 | 4 |
| 2005 | 4 | 1 | 5 |
| 2006 | 3 | 0 | 3 |
| 2007 | 3 | 1 | 4 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 2 | 3 |
| 2010 | 2 | 0 | 2 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, T-Cell" by people in Profiles.
-
Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity. Cancer Res. 2020 06 01; 80(11):2298-2310.
-
Inducible histone K-to-M mutations are dynamic tools to probe the physiological role of site-specific histone methylation in vitro and in vivo. Nat Cell Biol. 2019 11; 21(11):1449-1461.
-
Cutaneous histoplasmosis with prominent parasitization of epidermal keratinocytes: report of a case. J Cutan Pathol. 2016 Dec; 43(12):1155-1160.
-
Cutting off the power: inhibition of leukemia cell growth by pausing basal ATP release and P2X receptor signaling? Purinergic Signal. 2016 09; 12(3):439-51.
-
Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms. Oncotarget. 2015 Jun 20; 6(17):14953-69.
-
LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways. PLoS One. 2014; 9(1):e85883.
-
Nanoparticle delivery of inhibitory signal transducer and activator of transcription 3 G-quartet oligonucleotides blocks tumor growth in HMGA1 transgenic model of T-cell leukemia. Leuk Lymphoma. 2014 May; 55(5):1194-7.
-
HTLV-1 bZIP factor impedes the menin tumor suppressor and upregulates JunD-mediated transcription of the hTERT gene. Carcinogenesis. 2013 Nov; 34(11):2664-72.
-
"Whatever my mother wants": barriers to adequate pain management. J Palliat Med. 2013 Jun; 16(6):709-12.
-
HTLV-2 Tax immortalizes human CD4+ memory T lymphocytes by oncogenic activation and dysregulation of autophagy. J Biol Chem. 2012 Oct 05; 287(41):34683-93.